SILMEN-5

This brand name is authorized in Nigeria

Active ingredients

The drug SILMEN-5 contains a combination of these active pharmaceutical ingredients (APIs):

1 Meningococcal group A Polysaccharide (conjugated to TT)
UNII 1I86B47NY4 - NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE ANTIGEN
Read about Meningococcal serogroup A polysaccharide vaccine
2 Meningococcal group C Polysaccharide (conjugated to CRM197)
UNII 9B7N7Y96MK - NEISSERIA MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CRM-197 ADIPIC ACID CONJUGATE
Read about Meningococcal serogroup C polysaccharide vaccine
3 Meningococcal group Y Polysaccharide (conjugated to CRM197)
UNII CBZ4BH7TJ1 - NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE ANTIGEN
Read about Meningococcal serogroup Y polysaccharide vaccine
4 Meningococcal group W Polysaccharide (conjugated to CRM197)
UNII 9F8QQ6EER1 - NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE ANTIGEN
Read about Meningococcal serogroup W135 polysaccharide vaccine
5 Meningococcal group X Polysaccharide (conjugated to TT)
Read about Meningococcal serogroup X polysaccharide

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: NG Registered Drug Product Database Identifier(s): A6-100157

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈